Skip to content
High Tech Series A Founded 2020

Hanglok

Developer of surgical robot platforms and systems for minimally invasive procedures. Its current primary product is a remote master-slave interventional radiotherapy surgical robot, with ongoing research and development. Founded in 2020, headquartered in Zhuhai, China. The company has raised $29.0M in funding at the series a stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio…

📍 Zhuhai, China · Professional Service Robots,

Funding snapshot

Last roundSeries A
Amount$29M
Date1 September 2022
Total raised$29M

About

Developer of surgical robot platforms and systems for minimally invasive procedures. Its current primary product is a remote master-slave interventional radiotherapy surgical robot, with ongoing research and development. Founded in 2020, headquartered in Zhuhai, China. The company has raised $29.0M in funding at the series a stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio Venture Capital, Kangze Pharmaceutical. The company operates in High Tech > Professional Service Robots, Life Sciences > Surgical Instruments. Its business models include Professional Service Robots > Healthcare > Surgery > Vascular Intervention, Surgical Instruments > Robotic Surgery. Founded in 2020. Headquartered in China, Zhuhai. The company has raised funding at the Series A stage. Backed by investors including Proxima Ventures, Huatai Zijin Investment, Yuanbio Venture Capital, Kangze Pharmaceutical, Jiangsu Ruihua Investment Holding Group.

Business model

Professional Service Robots > Healthcare > Surgery > Vascular Intervention,

Surgical Instruments > Robotic Surgery

Institutional investors

Proxima Ventures Huatai Zijin Investment Yuanbio Venture Capital Kangze Pharmaceutical Jiangsu Ruihua Investment Holding Group

Latest coverage

No articles yet.

Raising like Hanglok?

Analyze your pitch deck before your next raise.

Analyze My Deck →